News

Teva Women’s Health has announced that its Plan B One-Step (levonorgestrel) tablet, 1.5mg emergency contraceptive is now available at licensed US retail pharmacies. Approved by the FDA on

RainDance Technologies and CLC bio have announced a partnership to develop specialised software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution

Details of the emerging technology were revealed during a lecture at the Health Protection Agency’s annual conference at the University of Warwick. “If there was a major radiological

Sosei Group (Sosei) has announced that Novartis have presented the results of their two phase II studies evaluating the efficacy, safety and tolerability of QVA149 at the annual

Pharming’s wholly-owned subsidiary DNage has initiated an observational study in children suffering from Cockayne Syndrome (CS). The study is designed to assess the natural (untreated) progression of the

Sanaria has received grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health in the form of a phase II Small

Cell Therapeutics (CTI) has released updated on 18-month follow-up clinical data for phase III EXTEND (PIX 301) trial of pixantrone (BBR2778) for patients with advanced, relapsed or refractory,

Progenics Pharmaceuticals has announced the promotion of Mark Baker to the newly created position of president. Mr Baker was also appointed to the Board of Directors. He will

Amgen has licensed the exclusive right to use ImmunoGen’s maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target found on solid tumors. Reportedly,